|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.183 USD | -2.66% |
|
+0.43% | -25.51% |
| 15/05 | Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024 | |
| 15/05 | Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q1 Revenue $1.9M, vs. Street Est of $2.1M | MT |
on January 2, 2019 Obalon Therapeutics, Inc. will transition Kelly Huang, Ph.D. to the role of Chief Executive Officer and Andy Rasdal to the role of Chairman of the Board.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.51% | 4.41M | |
| +7.63% | 223B | |
| +11.36% | 195B | |
| +18.52% | 144B | |
| +29.78% | 111B | |
| +2.32% | 65.19B | |
| +13.82% | 53.02B | |
| +2.68% | 50.28B | |
| +6.73% | 44.15B | |
| +1.88% | 36.45B |
RESHAPE LIFESCIENCES INC. 
